Medical Xpress August 5, 2024
In a first-of-its-kind study, a cohort of researchers, led by the University of Colorado Anschutz Medical Campus, evaluated the effects of state-level insulin out-of-pocket costs across states and payers and over time.
The team found that state-level caps on insulin out-of-pocket costs do not significantly increase insulin claims for patients with type 1 or patients using insulin to manage type 2 diabetes. Study results could help inform policies aimed at better delivering cost-capped insulin to patients struggling with insulin affordability.
Approximately one-quarter of patients who use insulin to manage diabetes have reported underuse due to the burden of cost, an issue state-mandated caps sought to alleviate. The study, published in Health Affairs, evaluated the effectiveness with which these caps make...
Today's Sponsors
Today's Sponsor